Stockscreener 앱 받기
0.6196
2.70%
0.0163
Vaxart Inc 주식(VXRT)의 최신 뉴스
Vaxart (NASDAQ:VXRT) Share Price Passes Below 200-Day Moving AverageWhat's Next? - MarketBeat
Vaxart Investors Win Class Cert. Over COVID Shot On 2nd Try - Law360
Vaxart Investors Get Class Status on Second Try Against Insider - Bloomberg Law
Contrasting Tenaya Therapeutics (NASDAQ:TNYA) and Vaxart (NASDAQ:VXRT) - Defense World
No time to wait on development of second-generation vaccines - The Hill
Vaxart (NASDAQ:VXRT) Share Price Crosses Below 200 Day Moving AverageTime to Sell? - MarketBeat
Akin Gump 'Totally Messed Up' With Texts, Vaxart Judge Says - Law360
Vaxart Hits Key Milestone in Phase 2b Oral COVID Vaccine Trial, Backed by $456M BARDA Deal - StockTitan
Vaxart, Inc. (NASDAQ:VXRT) Shares Sold by Sio Capital Management LLC - MarketBeat
Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside - AOL
VXRT (Vaxart) Enterprise Value : $95.98 Mil (As of Nov. 23, 2024) - GuruFocus.com
B. Riley Has Optimistic Outlook of Vaxart FY2024 Earnings - MarketBeat
COVID-19 vaccine company Vaxart under US federal investigation - Telegrafi
What is B. Riley's Estimate for Vaxart FY2027 Earnings? - MarketBeat
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Vaxart Grants 91.5K Equity Awards to New Employees Under Inducement Plan | VXRT Stock News - StockTitan
Investors Give Vaxart, Inc. (NASDAQ:VXRT) Shares A 29% Hiding - Simply Wall St
Vaxart Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Vaxart, Inc. Reports Third Quarter 2024 Financial Results – - Defense World
Vaxart, Inc. (NASDAQ:VXRT) Q3 2024 Earnings Call Transcript - Insider Monkey
Vaxart, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Earnings call: Vaxart reports progress in vaccine programs and financial growth - Investing.com
Vaxart Inc (NASDAQ: VXRT): Blank Check On Growth? - Stocks Register
VAXART, INC. (VXRT) Reports Q3 Loss, Tops Revenue Estimates - MSN
Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results - The Manila Times
Vaxart Inc (VXRT) Q3 2024 Earnings Call Highlights: Advancements in Oral Vaccine Platform and Financial Growth - GuruFocus.com
Vaxart Inc (VXRT) Q3 2024 Earnings Call Highlights: Advancements in Oral Vaccine Platform and ... - Yahoo Finance
Vaxart Inc reports results for the quarter ended September 30Earnings Summary - XM
Vaxart’s Q3 2024: Progress in Oral Vaccine Development - TipRanks
Vaxart's Q3 Revenue Jumps 133% to $4.9M, Narrows Losses Amid COVID Trial Progress | VXRT Stock News - StockTitan
Vaxart (VXRT) Scheduled to Post Earnings on Wednesday - MarketBeat
Vaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13 - The Manila Times
Vaxart (VXRT) Sets Q3 2024 Earnings Call for November 13: Key Updates Coming | VXRT Stock News - StockTitan
While shareholders of Vaxart (NASDAQ:VXRT) are in the black over 5 years, those who bought a week ago aren't so fortunate - Simply Wall St
Vaxart (NASDAQ:VXRT) Stock Price Passes Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Investing in Vaxart (NASDAQ:VXRT) five years ago would have delivered you a 127% gain - Yahoo Finance
VXRTVaxart, Inc Latest Stock News & Market Updates - StockTitan
Vaxart (NASDAQ:VXRT) Shares Cross Below 200 Day Moving AverageShould You Sell? - MarketBeat
Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024 - StockTitan
Millennium Management LLC Has $2.66 Million Stock Holdings in Vaxart, Inc. (NASDAQ:VXRT) - MarketBeat
Check out these key findings about Vaxart Inc (VXRT) - SETE News
Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need - StockTitan
VXRT stock rated an Outperform by Oppenheimer - Knox Daily
Did Vaxart Inc (VXRT) perform well in the last session? - US Post News
Best Penny Stocks Under $1 To Buy Now - AOL
Vaxart Inc (VXRT) Q2 2024 Earnings Call Highlights: Revenue Surge and Strategic Advances - Yahoo Finance
Vaxart ends agreement with sales agents, halts stock sales By Investing.com - Investing.com Australia
Vaxart, Inc. Terminates Controlled Equity Offering Sales Agreement with Sales Agents - MarketBeat
Vaxart ends agreement with sales agents, halts stock sales - Investing.com India
Vaxart Ends Sales Agreement, Halts Stock Offering - TipRanks
2.88%
2.65%
자본화:
|
볼륨(24시간):